DexCom (DXCM) : Traders are bullish on DexCom (DXCM) as it has outperformed the S&P 500 by a wide margin of 12.13% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 5.01%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 4.94% in the last 1 week, and is up 15.9% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The stock has recorded a 20-day Moving Average of 12.82% and the 50-Day Moving Average is 23.57%. DexCom, Inc. is up 39.83% in the last 3-month period. Year-to-Date the stock performance stands at 12.61%.
DexCom (NASDAQ:DXCM): stock turned positive on Friday. Though the stock opened at $90.33, the bulls momentum made the stock top out at $92.39 level for the day. The stock recorded a low of $89.7001 and closed the trading day at $92.23, in the green by 2.98%. The total traded volume for the day was 882,846. The stock had closed at $89.56 in the previous days trading.
Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products consist of DexCom G4, DexCom G4 PLATINUM and DexCom Share System. The DexCom G4 PLATINUM with Share uses a wireless connection between a patients receiver and an application on the patients iPhone to transmit glucose information to applications on the mobile devices of up to five designated recipients or followers, who can remotely monitor a patients glucose information and receive alert notifications anywhere they have an Internet connection. SweetSpots data transfer service is a Medical Device Data System (MDDS) and allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.